Gene Therapy and Emphysema Cambridge MA

A single treatment with a new method of gene therapy may offer lifetime protection against the progression of the lung disease emphysema, according to the results of a study in mice. The most common form of emphysema in young people is Alpha-1 Anti-trypsin Deficiency, caused by a mutation in the alpha-1 anti-trypsin gene, the authors of the study pointed out.

Edward Anthony Nardell, MD
(617) 665-1029
1493 Cambridge St
Cambridge, MA
Specialties
Internal Medicine, Pulmonary Diseases
Gender
Male
Education
Medical School: Hahnemann Univ Sch Of Med, Philadelphia Pa 19102
Graduation Year: 1972

Data Provided by:
Paula Pinkston
(617) 421-1000
133 Brookline Ave
Boston, MA
Specialty
Internal Medicine, Pulmonary Disease

Data Provided by:
Katherine P Hendra, MD
736 Cambridge St
Brighton, MA
Specialties
Internal Medicine, Pulmonary Critical Care Medicine
Gender
Female
Education
Medical School: New York Univ Sch Of Med, New York Ny 10016
Graduation Year: 1990

Data Provided by:
Rana Kaplan, MD
(617) 492-0872
1718 Massachusetts Ave
Cambridge, MA
Specialties
Internal Medicine, Pulmonary Critical Care Medicine
Gender
Female
Education
Medical School: Cornell Univ Med Coll, New York Ny 10021
Graduation Year: 1996

Data Provided by:
David Hillel Roberts
(617) 667-5864
330 Brookline Ave
Boston, MA
Specialty
Internal Medicine, Pulmonary Disease, Critical Care (Intensivists)

Data Provided by:
Sandeep Jain, MD
(954) 462-0911
Somerville, MA
Specialties
Internal Medicine, Pulmonary Critical Care Medicine
Gender
Male
Education
Medical School: S M S Med Coll, Univ Of Rajasthan, Jaipur, Rajasthan, India
Graduation Year: 1989

Data Provided by:
Scott Kenneth Epstein
(617) 789-3000
736 Cambridge St
Brighton, MA
Specialty
Internal Medicine, Pulmonary Disease, Critical Care (Intensivists)

Data Provided by:
Mark Daren Williams, MD
1 Joslin Pl
Boston, MA
Specialties
Internal Medicine, Pulmonary Critical Care Medicine
Gender
Male
Education
Medical School: In Univ Sch Of Med, Indianapolis In 46202
Graduation Year: 1990

Data Provided by:
Oscar Dinh Le, MD
(617) 636-5000
736 Cambridge St
Brighton, MA
Specialties
Internal Medicine, Pulmonary Critical Care Medicine
Gender
Male
Education
Medical School: Finch U Of Hs/Chicago Med Sch, North Chicago Il 60664
Graduation Year: 1997

Data Provided by:
Steven Elliot Weinberger, MD
(617) 667-4020
330 Brookline Ave
Boston, MA
Specialties
Internal Medicine, Pulmonary Diseases
Gender
Male
Education
Medical School: Harvard Med Sch, Boston Ma 02115
Graduation Year: 1973

Data Provided by:
Data Provided by:

Gene Therapy and Emphysema

Provided By:

TUESDAY, Dec. 22 (HealthDay News) -- A single treatment with a new method of gene therapy may offer lifetime protection against the progression of the lung disease emphysema, according to the results of a study in mice.

The most common form of emphysema in young people is Alpha-1 Anti-trypsin Deficiency, caused by a mutation in the alpha-1 anti-trypsin gene, the authors of the study pointed out.

In experiments on mice, researchers at the Boston University School of Medicine developed a system that can deliver genes selectively to as many as 70 percent of the lung's alveolar macrophages, which play an important role in emphysema.

Using this new approach, the researchers achieved sustained expression of normal human alpha-1 anti-trypsin (hAAT) protein at levels that improved emphysema in mice.

"The lung macrophages carrying the therapeutic gene survived in the lungs' air sacs for the two-year lifetime of the treated mice following a single intra-tracheal injection of the lentiviral vector we had engineered," study senior author Dr. Darrell Kotton, an associate professor of medicine and pathology and co-director of the Center for Regenerative Medicine at Boston University School of Medicine, said in a news release.

"Our results challenge the dogma that lung macrophages are short-lived and suggest these differentiated cells as a target cell that may be considered for in vivo gene therapy applications, including the sustained correction of hAAT deficiency," lead author Dr. Andrew Wilson, an assistant professor of medicine, said in the news release.

The study was published online Dec. 21 in the Journal of Clinical Investigation.

More information

The American Lung Association has more about emphysema.

SOURCE: Boston University Medical Center, news release, Dec. 21, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com